| (19) |
 |
|
(11) |
EP 3 124 624 A3 |
| (12) |
EUROPEAN PATENT APPLICATION |
| (88) |
Date of publication A3: |
|
12.04.2017 Bulletin 2017/15 |
| (43) |
Date of publication A2: |
|
01.02.2017 Bulletin 2017/05 |
| (22) |
Date of filing: 28.01.2010 |
|
| (51) |
International Patent Classification (IPC):
|
|
| (84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO
PL PT RO SE SI SK SM TR |
| (30) |
Priority: |
28.01.2009 EP 09450020
|
| (62) |
Application number of the earlier application in accordance with Art. 76 EPC: |
|
10701378.1 / 2391729 |
| (71) |
Applicants: |
|
- AIT Austrian Institute of Technology GmbH
1220 Wien (AT)
- tecnet equity NÖ Technologiebeteiligungs-Invest
GmbH
3100 St. Pölten (AT)
|
|
| (72) |
Inventors: |
|
- NÖHAMMER, Christa
1100 Vienna (AT)
- PICHLER, Rudolf
2485 Wampersdorf (AT)
- WEINHÄUSEL, Andreas
7311 Neckenmarkt (AT)
|
| (74) |
Representative: Sonn & Partner Patentanwälte |
|
Riemergasse 14
1010 Wien
1010 Wien (AT) |
|
| |
|
| (54) |
METHYLATION MARKERS FOR LUNG CANCER |
(57) The present invention discloses a method of generating subsets of methylation specific
markers from a set, having diagnostic power for various diseases, e.g. cancer of thyroid,
breast, colon, or leukemia, in diverse samples; identified subsets of that set, as
well as methods for the prognosis and diagnosis of diseases.